SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001510964-19-000027
Filing Date
2019-05-09
Accepted
2019-05-09 16:12:39
Documents
59
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cvsi-20190331x10q.htm 10-Q 575973
2 EXHIBIT 31.1 cvsi-20190331xex311.htm EX-31.1 10890
3 EXHIBIT 31.2 cvsi-20190331xex312.htm EX-31.2 10911
4 EXHIBIT 32.1 cvsi-20190331xex321.htm EX-32.1 5051
5 EXHIBIT 32.2 cvsi-20190331xex322.htm EX-32.2 4976
  Complete submission text file 0001510964-19-000027.txt   3719692

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cvsi-20190331.xml EX-101.INS 659365
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cvsi-20190331.xsd EX-101.SCH 29102
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cvsi-20190331_cal.xml EX-101.CAL 60344
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cvsi-20190331_def.xml EX-101.DEF 143203
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cvsi-20190331_lab.xml EX-101.LAB 472898
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cvsi-20190331_pre.xml EX-101.PRE 269524
Mailing Address 2688 SOUTH RAINBOW AVENUE, SUITE B LAS VEGAS NV 89146
Business Address 2688 SOUTH RAINBOW AVENUE, SUITE B LAS VEGAS NV 89146 866-290-2157
CV Sciences, Inc. (Filer) CIK: 0001510964 (see all company filings)

IRS No.: 800944970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54677 | Film No.: 19810662
SIC: 2834 Pharmaceutical Preparations